Complement-mediated tumor-specific cell lysis by antibody combinations targeting epidermal growth factor receptor (EGFR) and its variant III (EGFRvIII)

Katja Klausz, Sven Berger, Jeroen J. Lammerts van Bueren, Stefanie Derer, Stefan Lohse, Michael Dechant, Jan G.J. van de Winkel, Matthias Peipp, Paul W.H.I. Parren, Thomas Valerius^*

^*Korrespondierende/r Autor/-in für diese Arbeit